AbbVie
ABBV
ABBV
2,001 hedge funds and large institutions have $80.2B invested in AbbVie in 2019 Q3 according to their latest regulatory filings, with 123 funds opening new positions, 858 increasing their positions, 797 reducing their positions, and 124 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,001
Holders Change
-19
Holders Change %
-0.94%
% of All Funds
43.95%
Holding in Top 10
73
Holding in Top 10 Change
+21
Holding in Top 10 Change %
+40.38%
% of All Funds
1.6%
New
123
Increased
858
Reduced
797
Closed
124
Calls
$1.63B
Puts
$1.75B
Net Calls
-$116M
Net Calls Change
-$92.8M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.11B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$800M |
| 3 |
JPMorgan Chase & Co
New York
|
+$695M |
| 4 |
BlackRock
New York
|
+$253M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$221M |
